CNTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Context Therapeutics Inc (CNTX) is not a strong buy for a beginner, long-term investor at this time. The stock lacks positive momentum, has weak financial performance, and no significant catalysts or trading signals to suggest immediate upside. Holding off for now is advisable.
The technical indicators are mixed. While the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the MACD is negative and expanding downward, and RSI is neutral at 63.575. The price is below the pivot level of 2.413, indicating potential resistance ahead. Support levels are at 2.096 and 1.9, while resistance levels are at 2.73 and 2.926.
NULL identified. No news or significant events have been reported recently. The stock has an 80% chance of a minor 3.78% gain in the next month, but this is not a strong catalyst.
The company's financial performance is weak, with a significant YoY drop in net income (-44.48%) and EPS (-54.55%). The MACD is negative, and post-market trading shows a -1.90% decline. No insider or hedge fund activity indicates a lack of confidence.
In Q3 2025, the company reported zero revenue growth (0.00% YoY), a net income drop of -44.48% YoY to -$9,693,237, and an EPS decline of -54.55% YoY to -0.1. Gross margin remains at 0. These figures indicate poor financial health and no growth trends.
No recent analyst ratings or price target changes are available. Wall Street sentiment is neutral, with no strong opinions or recommendations on the stock.
